12:43 PM EDT, 09/19/2024 (MT Newswires) -- FibroBiologics ( FBLG ) said Thursday it engaged Southern Star Research to provide contract research organization services to the company in Australia.

Initial services cover preparatory work for a phase 1/2 study that will evaluate product candidate CYWC628 for the treatment of diabetic foot ulcers, FibroBiologics ( FBLG ) said.

Shares of the company were up 5.9% in recent trading.

Price: 3.43, Change: +0.19, Percent Change: +5.86